ХОБЛ_2

1.Agustí A.G. (2005) Systemic effects of chronic obstructive pulmonary disease / Proc. Am. Thorac.2005.Soc., 2(4): 367–370.

2.Antonelli-Incalzi R., Fuso L., De Rosa M. et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease / Eur. Respir. J., 1997., 10(12): 2794–2800.

3.Barzilay J.I., Abraham L., Heckbert S.R. The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study/ Diabetes., 2001. 50(10): 2384–2389.

4.Boyd C.M., Darer J., Boult C. et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance /JAMA, 2005. 294(6): 716–724.

5.Brody J.S. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer / Proc. Am. Thorac. Soc., 2006. 3(6): 535–537.

6.Celli B.R., Cote C.G., Marin J.M. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease / N. Engl. J. Med., 2004. 350(10): 1005–1012.

7.Charlson M., Charlson R.E., Briggs W., Hollenberg J. Can disease management target patients most likely to generate high costs? The impact of comorbidity. /J. Gen. Intern. Med.,2007. 22(4): 464–469.

8.de Torres J.P., Cordoba-Lanus E., López-Aguilar C. et al. C-reactive protein levels and clinically important predictive outcomes in stable COPD patients /Eur. Respir. J., 2006. 27(5): 902–907.

9.Eisner M.D., Yelin E.H., Trupin L., Blanc P.D. The influence of chronic respiratory conditions on health status and work disability / Am. J. Public Health, 2002. 92(9): 1506–1513.

10.Engström G., Hedblad B., Valind S., Janzon L. Increased incidence of myocardial infarction and stroke in hypertensive men with reduced lung function / J. Hypertens., 2001.19(2): 295–301.

11.Epping-Jordan J.E., Galea G., Tukuitonga C., Beaglehole R. Preventing chronic diseases: taking stepwise action / Lancet, 2005. 366(9497): 1667–1671.

12.Fabbri L.M., Ferrari R. Chronic disease in the elderly: back to the future of internal medicine /Breathe, 2006.3(1): 40–49.

13.Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis /Thorax, 2004.59(7): 574–580.

14.Hansell A.L., Walk J.A., Soriano J.B. What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis/ Eur. Respir. J., 2003. 22(5): 809–814.

15.Holguin F., Folch E., Redd S.C., Mannino D.M. Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001 /Chest, 2005. 128(4): 2005–2011.

16.Jensen H.H., Godtfredsen N.S., Lange P., Vestbo J. Potential misclassification of causes of death from COPD /Eur. Respir. J., 2006. 28(4): 781–785.

17.Kasahara Y., Tuder R.M., Taraseviciene-Stewart L. et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema /J. Clin. Invest., 2000. 106(11): 1311–1319.

28. Litonjua A.A., Lazarus R., Sparrow D. et al. Lung function in type 2

diabetes: the Normative Aging Study /Respir. Med., 2005. 99(12): 1583–1590.

19.Lopez A.D., Mathers C.D., Ezzati M. et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data /Lancet, 2006. 367(3524): 1747–1757.

20.Mannino D.M., Buist A.S. Global burden of COPD: risk factors, prevalence, and future trends /Lancet, 2007. 370(9589): 765–773.

21.Mannino D.M., Doherty D.E., Sonia Buist A. Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study /Respir. Med., 2006. , 100(1): 115–122.

22.Mannino D.M., Thorn D., Swensen A., Holguin F. Prevalence and outcomes of diabetes, hypertension, and cardiovascular disease in COPD / Eur. Respir. J., 2008. 32(4): 962–969.

23.Mannino DM. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity /Chest., 2002; 121: Suppl. 5, 121S-126S.

24.Sin D.D., Man S.F. (2005) Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality /Proc. Am. Thorac. Soc., 2(1): 8–11.

25.Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities /Eur Respir J., 2006; 28: 1245-1257.

26.Yong RP., Hopkins RJ., Eaton TE. Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes. /Eur Respir J., 2007; 30: 616-622.

Давидовская Елена Игнатьевна к.м.н. доцент кафедры клинической фармакологии и терапии

БелМАПО

тел. Моб. VEL 8029 611 63 53 E-mail: [e-mail]